✦ LIBER ✦

Baseline characteristics of elderly patients receiving dabigatran etexilate for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation

✍ Scribed by A. Vilches-Moraga; L. Garrido-González; C. Rodriguez-Pascual; E. Paredes-Galán; A. Alvarez-Pérez; J.C. Taboada-Rodriguez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety profile and efficacy of dabigatra

✍ A. Vilches-Moraga; J.C. Taboada-Rodriguez; C. Rodriguez-Pascual; E. Paredes-Galá 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 87 KB

Factors associated with increased mortal

✍ A. Vilches-Moraga; A. Alvarez-Pérez; E. Paredes-Galán; C. Rodriguez-Pascual; J.C 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 77 KB

PCV60 Cost Effectiveness of Dabigatran E

✍ S. Kececioglu; P. Ulus; F. Cukadar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Dabigatran versus rivaroxaban for the pr

✍ Kansal, A. R.; Sharma, M.; Bradley-Kennedy, C.; Clemens, A.; Monz, B. U.; Peng, 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 173 KB

PCV60 Cost-Effectiveness of Dabigatran f

✍ D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Warfarin for the prevention of systemic

✍ Andersen, L V; Vestergaard, P; Deichgraeber, P; Lindholt, J S; Mortensen, L S; F 📂 Article 📅 2008 🏛 BMJ 🌐 English ⚖ 435 KB